Blood Collection Market Analysis By Product (Needles And Syringes, Blood Collection Tubes [EDTA, Heparin, Serum-Separating, Plasma-Separating], Blood Bags), By Application (Diagnostics, Treatment), By End-Use, And Segment Forecasts, 2018 - 2025

Industry Insights

The global blood collection market size was valued at USD 7.6 billion in 2015 and is projected to grow at 6.1% over the forecast period. Increasing prevalence ofinfectious and non-communicable diseases, mounting number of accident & trauma cases are the major factors contributing toward the growth. According to the CDC, in 2013, around 27.6 million and 20.3 million adults were diagnosed with heart disease and cancer respectively in the U.S. Therefore, the demand for blood collection products for diagnostics application is expected to grow at a high rate in the near future.

Increasing number of surgical procedures is another major factor considerably promoting toward the growth of the market. According to the WHO, in 2012, around 266.2 to 359.5 million surgical procedures were performed globally and this number is expected to increase in the near future. The increase in the number of surgical procedures such as organ transplant and cancer surgeries that require blood transfusion is expected to propel the application of these products of the target market. Thus, the demand for needles, syringes, tubes, and blood bags is growing for the diagnostics and treatment application, which is expected to drive the growth.

North America blood collection market share, by application, 2015

Product Insights

On the basis of product, the market is categorized into blood collection needles and syringes, tubes, bags, and others. In 2015, needles and syringes was the largest revenue generating segment and is also projected to uphold its dominance during the forecast period. The high demand of syringes and needles in diseases diagnosis and surgical procedures is the major factor contributing to the growth of this segment. In addition, these products are easy-to-handle and economical. These factors drive its application for diagnostics and therapeutic purposes.

The blood collection tube segment is expected to showcase lucrative growth during the forecast period. The increase in the prevalence of diseases drives the demand for blood testing and subsequently for blood collection tubes. In addition, product advancement is another major factor that propels the adoption of blood collection tubes. For instance, in September 2016, BD’s Vacutainer Barricor plasma blood collection tube received FDA clearance. This is an advanced blood collection and separation product that provides improved sample quality, clinical efficiency, faster test results, and improved patient care.

Application Insights

The market is classified into diagnostics and treatment on the basis of its application. The diagnostics application segment accounted for major revenue share of the market in 2015. Various conditions such as infectious diseases, diabetes, cancer, anemia, and sickle cell require frequent blood testing. Thus, the demand for blood collection products for diagnostics application is high and is expected to remain on the rise throughout the study period.

Diagnostics segment is expected to witness fastest growth rate over the forecast period. The introduction of advanced products and government initiatives to prevent prevalence of infectious diseases is expected to boost the growth in the near future.

End-Use Insights

The hospitals dominated the market in 2015 due to the growing number of surgical procedures and accidental cases. According to the CDC, around 31.0 million people annually visit the emergency department for accidental or unintentional injuries in the U.S. In addition, increasing number of patients suffering with infectious diseases is expected to boost the growth of the segment.

The hospitals segment is also anticipated to grow at fastest rate over the forecast period. The growing healthcare awareness as well as initiatives by the government and nongovernment organizations, to control and prevent infectious diseases is a major factor responsible for the market growth. For instance, the CDC has begun to collaborate with the government of South Africa to develop national HIV clinical & research guidelines, conduct epidemiology training, and support HIV & TB programs.

The U.S. blood collection market, by end-use, 2014-2025 (USD Million)

Regional Insights

The North America dominated the overall market in 2015. The presence of highly developed healthcare infrastructure and high per capita healthcare expenditure drive the growth in this region. In addition, rapid adoption of advanced products in the U.S. boost the demand for target products.

Asia Pacific is estimated to grow at the highest rate during the forecast period due to increasing geriatric population and rising prevalence of infectious diseases such as HIV infection, tuberculosis, and malaria in this region. In addition, rapidly developing healthcare infrastructure in the Asian countries such as India and China are expected to drive the growth.

Competitive Insights

Some of the key players comprises of Abbott Laboratories; Terumo Corp.; Becton, Dickinson and Company; NIPRO Medical Corp.; Medtronic; Qiagen; and FL MEDICAL s.r.l. Altogether, these companies held the largest market share in 2015.

The major companies are undertaking several organic as well as inorganic strategies such as collaborations, new product development, acquisitions, and regional expansion to gain maximum share in the industry. For instance, in March 2015, Becton, Dickinson and Company acquired CareFusion Corp. to expand its product portfolio and geographical reach across the globe.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the blood collection market on the basis of product, application, end-use, and region:

• Product Outlook (Revenue, USD Million; 2014 - 2025)

  • Needles and Syringes

  • EDTA Tubes

  • Heparin Tubes

  • Serum-separating Tubes

  • Plasma-separating Tubes

  • Blood Bags

  • Others

• Application Outlook (Revenue, USD Million; 2014 - 2025)

  • Diagnostics

  • Treatment

• End-Use Outlook (Revenue, USD Million; 2014 - 2025)

  • Hospitals

  • Diagnostics Centers

  • Blood Banks

  • Others

• Regional Outlook (Revenue, USD Million; 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa